Zhaoke Ophthalmology Achieves Positive Topline Results from the Two-Year Phase III Clinical Trial of its Myopia Drug NVK002

Zhaoke Ophthalmology Completes the Last Patient Last Visit in its Phase III Clinical Trial of TAB014 in China

Zhaoke Ophthalmology’s Bimatoprost Eye Drop (晶贝清®) Obtains Regulatory Approval for Commercialization

Zhaoke Ophthalmology Announces 2024 Interim Results

Zhaoke Ophthalmology Obtains IND Approval for Phase III Trial of CsA Ophthalmic Gel and Completes the Last Patient Last Visit in its Phase III China CHAMP Trial of NVK002